# A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function

> **NCT01522950** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 76 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** atenolol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01522950
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522950, "A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01522950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*